Cardinal Health Inc (CAH) : Cincinnati Insurance Co added new position in Cardinal Health Inc during the most recent quarter end. The investment management firm now holds 575,526 shares of Cardinal Health Inc which is valued at $48,119,729 , the company said in a statement filed on Aug 9, 2016 with the SEC.Cardinal Health Inc makes up approximately 1.55% of Cincinnati Insurance Co’s portfolio.
Other Hedge Funds, Including , Glassman Wealth Services boosted its stake in CAH in the latest quarter, The investment management firm added 200 additional shares and now holds a total of 1,165 shares of Cardinal Health Inc which is valued at $97,406. Cardinal Health Inc makes up approx 0.08% of Glassman Wealth Services’s portfolio.Sit Investment Associates Inc reduced its stake in CAH by selling 288,900 shares or 44.53% in the most recent quarter. The Hedge Fund company now holds 359,840 shares of CAH which is valued at $30,082,624. Cardinal Health Inc makes up approx 0.77% of Sit Investment Associates Inc’s portfolio.Cibc World Markets reduced its stake in CAH by selling 26,811 shares or 83.5% in the most recent quarter. The Hedge Fund company now holds 5,297 shares of CAH which is valued at $439,598. Donald L. Hagan added CAH to its portfolio by purchasing 11,991 company shares during the most recent quarter which is valued at $995,133. Cardinal Health Inc makes up approx 0.93% of Donald L. Hagan’s portfolio.Sumitomo Life Insurance Co reduced its stake in CAH by selling 708 shares or 3.39% in the most recent quarter. The Hedge Fund company now holds 20,149 shares of CAH which is valued at $1,676,598. Cardinal Health Inc makes up approx 0.22% of Sumitomo Life Insurance Co’s portfolio.
Cardinal Health Inc opened for trading at $82.88 and hit $82.99 on the upside on Wednesday, eventually ending the session at $82.78, with a gain of 0.12% or 0.1 points. The heightened volatility saw the trading volume jump to 14,91,923 shares. Company has a market cap of $26,373 M.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.